iBio (IBIO) Preferred Dividend Payments (2017 - 2021)

iBio's (IBIO) quarterly Preferred Dividend Payments came in at $22000.0 in Q4 2021, down 66.15% year-on-year from $65000.0 in Q4 2020, and down 66.67% on a QoQ basis from $66000.0 in Q3 2021.

iBio (IBIO) Preferred Dividend Payments (2017 - 2021) Analysis & Trends

iBio (IBIO) has 5 years of Preferred Dividend Payments data on file, last reported at $22000.0 in Q4 2021.

  • On a quarterly basis, Preferred Dividend Payments fell 66.15% year-over-year to $22000.0 in Q4 2021; TTM through Sep 2022 was $22000.0, a 91.54% decrease from a year earlier, with the FY2022 full-year figure at $88000.0, down 66.15% from the prior year.
  • Preferred Dividend Payments for Q4 2021 stood at $22000.0, down from $66000.0 in the prior quarter.
  • Over the last five years, Preferred Dividend Payments for IBIO reached as high as $66000.0 in Q3 2017 and fell as low as $22000.0 in Q4 2021.
  • Historically, Preferred Dividend Payments has averaged $60950.0 across 5 years, with a median of $65000.0 in 2017.
  • Across the five-year window, Preferred Dividend Payments jumped 146.15% in 2018 and slumped 66.15% in 2021, its largest moves.
  • Year by year, Preferred Dividend Payments stood at $65000.0 in 2017, then changed by 0.0% to $65000.0 in 2018, then changed by 0.0% to $65000.0 in 2019, then changed by 0.0% to $65000.0 in 2020, then slumped by 66.15% to $22000.0 in 2021.
  • Per Business Quant data, the three most recent Preferred Dividend Payments figures were $22000.0 in Q4 2021, $66000.0 in Q3 2021, and $65000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn - -
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn - -
3 Akari Therapeutics 1,023.69 Bn 1,023.69 Bn - -
4 BeOne Medicines 468.59 Bn 463.80 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 123.01 Bn 115.76 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.29 Bn 61.53 Bn 3.31 Bn -
7 Belite Bio 63.33 Bn 63.33 Bn - -
8 Argenx Se 55.70 Bn 50.52 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.79 Bn 34.78 Bn 959.66 Mn -
10 iBio 166.84 Mn 166.84 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 22,000.00
Sep 30, 2021 66,000.00
Jun 30, 2021 65,000.00
Mar 31, 2021 64,000.00
Dec 31, 2020 65,000.00
Sep 30, 2020 66,000.00
Jun 30, 2020 65,000.00
Mar 31, 2020 65,000.00
Dec 31, 2019 65,000.00
Sep 30, 2019 66,000.00
Jun 30, 2019 65,000.00
Mar 31, 2019 64,000.00
Dec 31, 2018 65,000.00
Sep 30, 2018 66,000.00
Jun 30, 2018 65,000.00
Mar 31, 2018 64,000.00
Dec 31, 2017 65,000.00
Sep 30, 2017 66,000.00
Jun 30, 2017 64,000.00
Mar 31, 2017 26,000.00